We welcome you to join our Risk & Pharmacovigilance MasterClass on the 28 - 29 May 2020 in the historical city of Vienna, Austria. The MasterClass will be led by Dimitris Zampatis, Associate director, Signal and Risk Management Process at Merck Biopharma, Germany.
The focus of this two-day masterclass will be on providing an update of ongoing medicines' risk and signal management. Participants will also have the opportunity to get an insight into the current signal detection and management guidelines and tools. During this training, an outlook of current and future challenges in pharmacovigilance focusing on the impact of the General Data Protection Regulation (GDPR) in May 2018 will be given and discussed.
By the end of this training, participants will:
- Learn all the details about the RMP Structure and compilation
- Discover the risk minimization measures
- Have a closer look at the signal detection and the MAH experience in EVDAS
- Get to know the EU guidelines and the authorities expectation on signal management
Comments